Aug 24, 2026 04:47AM
Aug 5, 2026 07:21AM
Jul 28, 2026 06:00AM
Jul 17, 2026 04:16PM
Jul 13, 2026 02:14PM
Jul 13, 2026 02:09PM
Jul 13, 2026 10:58AM Wells Fargo Upgrades Q32 Bio Inc. (QTTB) to Overweight
Jul 13, 2026 09:33AM
Jul 13, 2026 06:59AM
Jul 10, 2026 04:06PM
Jun 25, 2026 04:15PM
May 27, 2026 08:41AM
May 22, 2026 04:19AM
May 18, 2026 06:16AM Cantor Fitzgerald Starts Q32 Bio Inc. (QTTB) at Overweight
May 5, 2026 07:46AM
Mar 10, 2026 12:20PM
Mar 10, 2026 08:42AM
Feb 25, 2026 06:06AM
Dec 19, 2025 04:09PM
Dec 18, 2025 05:57AM
Dec 1, 2025 07:07AM Q32 Bio sells complement inhibitor ADX-097 to Akebia for $12 million
Nov 13, 2025 07:42AM
Aug 6, 2025 07:59AM
Jun 25, 2025 06:59AM
May 8, 2025 04:46PM
Apr 30, 2025 07:00AM
Apr 16, 2025 07:02AM
Mar 20, 2025 04:24PM Oppenheimer Reiterates Outperform Rating on Q32 Bio Inc. (QTTB), PT $20
Mar 11, 2025 04:53PM
Feb 11, 2025 07:26AM
Feb 11, 2025 03:09AM
Feb 10, 2025 04:05PM
Dec 12, 2024 09:04AM
Dec 11, 2024 07:25AM
Dec 11, 2024 06:37AM Q32 Bio Inc. (QTTB) PT Lowered to $20 at Oppenheimer
Dec 11, 2024 06:20AM
Dec 11, 2024 05:41AM
Dec 11, 2024 02:52AM
Dec 10, 2024 04:50PM
Dec 10, 2024 04:21PM
Dec 5, 2024 04:10PM
Oct 16, 2024 06:22AM Oppenheimer Reiterates Outperform Rating on Q32 Bio Inc. (QTTB)
Sep 11, 2024 05:56AM
Aug 19, 2024 05:51AM
Aug 8, 2024 09:22AM
Jul 9, 2024 06:59AM
Jul 1, 2024 06:59AM

456,369 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All